DaVita HealthCare Partners Inc (DVA)
Days of sales outstanding (DSO)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables turnover | 5.03 | 5.01 | 4.96 | 4.90 | 4.55 | 4.67 | 4.41 | 4.64 | 4.82 | 4.65 | 4.53 | 4.43 | 4.74 | 4.75 | 4.74 | 4.85 | 4.94 | 4.73 | 4.41 | 4.55 | |
| DSO | days | 72.64 | 72.86 | 73.60 | 74.54 | 80.19 | 78.20 | 82.72 | 78.61 | 75.73 | 78.52 | 80.50 | 82.45 | 77.07 | 76.78 | 76.93 | 75.33 | 73.88 | 77.18 | 82.75 | 80.30 |
December 31, 2023 calculation
DSO = 365 ÷ Receivables turnover
= 365 ÷ 5.03
= 72.64
DaVita Inc's days of sales outstanding (DSO) has shown a decreasing trend over the past two quarters, from 80.19 days in Q4 2022 to 72.64 days in Q4 2023. This indicates an improvement in the company's ability to collect payments from its customers in a timely manner. However, DSO increased steadily throughout 2022, reaching a peak of 82.72 days in Q2 2022, before gradually declining in the second half of the year. Overall, DaVita Inc's DSO performance has been relatively stable, with minor fluctuations quarter over quarter. The company should continue to focus on managing its accounts receivable effectively to maintain this positive trend in DSO.
Peer comparison
Dec 31, 2023